Search research articles
Contact Us
Filters
Showing results (1-10 of 140) with videos related to
Page
of 14
Sort By:
Blood
|
August 23, 2014
Asparaginase allergies: it's all in the genes
Meir Wetzler
Hematology/Oncology Clinics of North America
|
October 15, 2009
Preface: acute lymphoblastic leukemia--quo vadis?
Meir Wetzler, Wendy Stock
Leukemia Research Reports
|
December 28, 2013
Short communications and case reports-Who cares?
Suneel Mundle, Meir Wetzler
Current Pharmaceutical Design
|
February 8, 2011
Omacetaxine as an anticancer therapeutic: what is old is new again
Meir Wetzler, David Segal
Leukemia & Lymphoma
|
February 28, 2007
Targeting CD40
Eunice S Wang, Meir Wetzler
Leukemia & Lymphoma
|
February 16, 2013
Homoharringtonine and granulocyte colony-stimulating factor priming for acute myeloid leukemia: is it ready for prime time?
Omar Al Ustwani, Meir Wetzler
Journal of Pharmacy Practice
|
February 26, 2015
An oncologist's perspective on metformin use and acute lymphoblastic leukemia outcomes
Eunice S Wang, Meir Wetzler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2011
Therapeutic advances in acute myeloid leukemia
Alan Burnett, Meir Wetzler, Bob Löwenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2009
Targeting signal transducer and activator of transcription signaling pathway in leukemias
Mustafa Benekli, Heinz Baumann, Meir Wetzler
Expert Opinion on Biological Therapy
|
December 10, 2008
Pegasparaginase: where do we stand?
Amer Zeidan, Eunice S Wang, Meir Wetzler
Page
of 14
Search research articles
Search
Showing results (1-10 of 140) with videos related to
Sort By:
Page
of 14
Blood
|
August 23, 2014
Asparaginase allergies: it's all in the genes
Meir Wetzler
Hematology/Oncology Clinics of North America
|
October 15, 2009
Preface: acute lymphoblastic leukemia--quo vadis?
Meir Wetzler, Wendy Stock
Leukemia Research Reports
|
December 28, 2013
Short communications and case reports-Who cares?
Suneel Mundle, Meir Wetzler
Current Pharmaceutical Design
|
February 8, 2011
Omacetaxine as an anticancer therapeutic: what is old is new again
Meir Wetzler, David Segal
Leukemia & Lymphoma
|
February 28, 2007
Targeting CD40
Eunice S Wang, Meir Wetzler
Leukemia & Lymphoma
|
February 16, 2013
Homoharringtonine and granulocyte colony-stimulating factor priming for acute myeloid leukemia: is it ready for prime time?
Omar Al Ustwani, Meir Wetzler
Journal of Pharmacy Practice
|
February 26, 2015
An oncologist's perspective on metformin use and acute lymphoblastic leukemia outcomes
Eunice S Wang, Meir Wetzler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2011
Therapeutic advances in acute myeloid leukemia
Alan Burnett, Meir Wetzler, Bob Löwenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2009
Targeting signal transducer and activator of transcription signaling pathway in leukemias
Mustafa Benekli, Heinz Baumann, Meir Wetzler
Expert Opinion on Biological Therapy
|
December 10, 2008
Pegasparaginase: where do we stand?
Amer Zeidan, Eunice S Wang, Meir Wetzler
Page
of 14